1887

Journal of Medical Microbiology logo

Volume 61, Issue 2

Increased expression of virulence attributes in oral isolates from human immunodeficiency virus-positive individuals Free

Abstract

Oral candidiasis caused by is recognized as one of the most frequent opportunistic infections in human immunodeficiency virus (HIV)-infected individuals. The overall severity and chronicity of oral candidiasis has been attributed exclusively to the HIV-induced immune deficiency of the affected individuals but not to the virulence factors of the pathogen, i.e. . However, genotypic and phenotypic studies have suggested that HIV infection might be associated with preferential selection of strains with altered virulence determinants, leading to colonization with populations that are better able to cause disease in these immunologically compromised hosts. If this process of selection is indeed related to pathogenicity, it may be possible to measure alterations in different virulence factors produced by in HIV-infected patients. To evaluate this hypothesis, the present work was undertaken to determine simultaneously the expression of five virulence factors in oral isolates colonizing and infecting HIV-positive and -negative individuals. The significance of genotypes in the pathogenesis of oral candidiasis was also elucidated. Oral swabs were collected from 335 consecutive individuals (210 HIV-positive and 125 HIV-negative). Virulence factors and genotypes were determined for all the strains isolated. The results showed significantly increased expression of proteinase, phospholipase and haemolytic activities, as well as a greater ability to adhere, in isolates from HIV-positive compared with HIV-negative individuals (<0.05). However, no significant differences in virulence factor expression in isolates colonizing or infecting HIV-positive individuals were seen. Genotype A was the predominant type (71.3 %); however, a relationship could not be established between the genotypes and the virulence factors, or with clinical infection. These data support the concept of preferential strain selection with altered virulence determinants in HIV-infected individuals and emphasize the need for further molecular genetic linkage studies that could be helpful in dissecting the molecular causes of preferential strain selection, which may lead to new approaches for therapeutic intervention.

  • Received:
  • Accepted:
  • Published Online:
© 2012 SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.036269-0
2012-02-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/2/285.html?itemId=/content/journal/jmm/10.1099/jmm.0.036269-0&mimeType=html&fmt=ahah

References

  1. Abaci O. 2011; Investigation of extracellular phospholipase and proteinase activities of Candida species isolated from individuals denture wearers and genotypic distribution of Candida albicans strains. Curr Microbiol 62:1308–1314 [View Article][PubMed]
     [Google Scholar]
  2. Al-Abeid H. M., Abu-Elteen K. H., Elkarmi A. Z., Hamad M. A. 2004; Isolation and characterization of Candida spp. in Jordanian cancer patients: prevalence, pathogenic determinants, and antifungal sensitivity. Jpn J Infect Dis 57:279–284[PubMed]
     [Google Scholar]
  3. Aoki S., Ito-Kuwa S., Nakamura Y., Masuhara T. 1990; Comparative pathogenicity of a wild-type strain and respiratory mutants of Candida albicans in mice. Zentralbl Bakteriol 273:332–343[PubMed] [CrossRef]
     [Google Scholar]
  4. Borst A., Fluit A. C. 2003; High levels of hydrolytic enzymes secreted by Candida albicans isolates involved in respiratory infections. J Med Microbiol 52:971–974 [View Article][PubMed]
     [Google Scholar]
  5. Calderone R. A., Fonzi W. A. 2001; Virulence factors of Candida albicans . Trends Microbiol 9:327–335 [View Article][PubMed]
     [Google Scholar]
  6. Costa C. R., Passos X. S., Souza L. K., Lucena P. A., Fernandes O. F., Silva M. R. 2010; Differences in exoenzyme production and adherence ability of Candida spp. isolates from catheter, blood and oral cavity. Rev Inst Med Trop Sao Paulo 52:139–143 [View Article][PubMed]
     [Google Scholar]
  7. Gokce G., Cerikcioglu N., Yagci A. 2007; Acid proteinase, phospholipase, and biofilm production of Candida species isolated from blood cultures. Mycopathologia 164:265–269 [View Article][PubMed]
     [Google Scholar]
  8. Hung C.-C., Yang Y.-L., Lauderdale T.-L., McDonald L. C., Hsiao C.-F., Cheng H.-H., Ho Y. A., Lo H.-J. 2005; Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species. J Clin Microbiol 43:1600–1603 [View Article][PubMed]
     [Google Scholar]
  9. Jain P. A., Veerabhadrudu K., Kulkarni R. D., Ajantha G. S., Shubhada C., Amruthkishan U. 2010; Comparative study of adherence of oral Candida albicans isolates from HIV sero-positive individuals and HIV sero-negative individuals to human buccal epithelial cells. Indian J Pathol Microbiol 53:513–517 [View Article][PubMed]
     [Google Scholar]
  10. Koga-Ito C. Y., Lyon J. P., Vidotto V., de Resende M. A. 2006; Virulence factors and antifungal susceptibility of Candida albicans isolates from oral candidosis patients and control individuals. Mycopathologia 161:219–223 [View Article][PubMed]
     [Google Scholar]
  11. Kumar C. P., Kumar S. S., Menon T. 2006; Phospholipase and proteinase activities of clinical isolates of Candida from immunocompromised patients. Mycopathologia 161:213–218 [View Article][PubMed]
     [Google Scholar]
  12. Lee K. L., Buckley H. R., Campbell C. C. 1975; An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans . Sabouraudia 13:148–153 [View Article][PubMed]
     [Google Scholar]
  13. Luo G., Samaranayake L. P., Yau J. Y. 2001; Candida species exhibit differential in vitro hemolytic activities. J Clin Microbiol 39:2971–2974 [View Article][PubMed]
     [Google Scholar]
  14. Mane A., Panchvalli S., Bembalkar S., Risbud A. 2010; Species distribution & antifungal susceptibility of oral Candida colonising or infecting HIV-infected individuals. Indian J Med Res 131:836–838[PubMed]
     [Google Scholar]
  15. Menezes E. A., Monterio M. N., Parente T. M., Cunha F. A., Augusto K. L., Freire C. C. F. 2006; Frequency and enzymatic activity of Candida albicans isolated from the oral cavity of HIV-positive patients at Fortaleza, Ceará. J Bras Patol Med Lab 42:253–256 [CrossRef]
     [Google Scholar]
  16. Miyasaki S. H., Hicks J. B., Greenspan D., Polacheck I., MacPhail L. A., White T. C., Agabian N., Greenspan J. S. 1992; The identification and tracking of Candida albicans isolates from oral lesions in HIV-seropositive individuals. J Acquir Immune Defic Syndr 5:1039–1046[PubMed]
     [Google Scholar]
  17. Morrow B., Anderson J., Wilson J., Soll D. R. 1989; Bidirectional stimulation of the white–opaque transition of Candida albicans by ultraviolet irradiation. J Gen Microbiol 135:1201–1208[PubMed]
     [Google Scholar]
  18. Nawrot U., Skała J., Włodarczyk K., Fonteyne P. A., Nolard N., Nowicka J. 2008; Proteolytic activity of clinical Candida albicans isolates in relation to genotype and strain source. Pol J Microbiol 57:27–33[PubMed]
     [Google Scholar]
  19. Ollert M. W., Wende C., Görlich M., McMullan-Vogel C. G., Borg-von Zepelin M., Vogel C. W., Korting H. C. 1995; Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J Clin Microbiol 33:2543–2549[PubMed]
     [Google Scholar]
  20. Pereiro M. J. Jr, Losada A., Toribio J. 1997; Adherence of Candida albicans strains isolated from AIDS patients. Comparison with pathogenic yeasts isolated from patients without HIV infection. Br J Dermatol 137:76–80 [View Article][PubMed]
     [Google Scholar]
  21. Sacristán B., Blanco M. T., Galán-Ladero M. A., Blanco J., Pérez-Giraldo C., Gómez-García A. C. 2011; Aspartyl proteinase, phospholipase, hemolytic activities and biofilm production of Candida albicans isolated from bronchial aspirates of ICU patients. Med Mycol 49:94–97 [View Article][PubMed]
     [Google Scholar]
  22. Schmid J., Odds F. C., Wiselka M. J., Nicholson K. G., Soll D. R. 1992; Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting. J Clin Microbiol 30:935–941[PubMed]
     [Google Scholar]
  23. Shinobu C. M., Ogatta S. F. Y., Bizerra F., Furlaneto L., Peralta R. M., Svidzinski T. I. E., Consolaro M. E. L. 2007; Lack of association between genotypes and virulence factors in C. albicans strains isolated from vaginal secretion. Braz J Microbiol 38:467–471 [View Article]
     [Google Scholar]
  24. Sugita T., Kurosaka S., Yajitate M., Sato H., Nishikawa A. 2002; Extracellular proteinase and phospholipase activity of three genotypic strains of a human pathogenic yeast, Candida albicans . Microbiol Immunol 46:881–883[PubMed] [CrossRef]
     [Google Scholar]
  25. Sweet S. P., Cookson S., Challacombe S. J. 1995; Candida albicans isolates from HIV-infected and AIDS patients exhibit enhanced adherence to epithelial cells. J Med Microbiol 43:452–457 [View Article][PubMed]
     [Google Scholar]
  26. Tsang C. S., Samaranayake L. P. 1999; Factors affecting the adherence of Candida albicans to human buccal epithelial cells in human immunodeficiency virus infection. Br J Dermatol 141:852–858 [View Article][PubMed]
     [Google Scholar]
  27. Tsang C. S. P., Chu F. C., Leung W. K., Jin L. J., Samaranayake L. P., Siu S. C. 2007; Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. J Med Microbiol 56:1393–1398 [View Article][PubMed]
     [Google Scholar]
  28. Vargas K., Messer S. A., Pfaller M., Lockhart S. R., Stapleton J. T., Hellstein J., Soll D. R. 2000; Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode. J Clin Microbiol 38:3595–3607[PubMed]
     [Google Scholar]
  29. Wu T., Samaranayake L. P., Cao B. Y., Wang J. 1996; In-vitro proteinase production by oral Candida albicans isolates from individuals with and without HIV infection and its attenuation by antimycotic agents. J Med Microbiol 44:311–316 [View Article][PubMed]
     [Google Scholar]
  30. Yenişehirli G., Bulut Y., Tunçoglu E. 2010; [Phospholipase, proteinase and hemolytic activities of Candida albicans isolates obtained from clinical specimens]. Mikrobiyol Bul 44:71–77 (in Turkish) [PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.036269-0
Loading
Increased expression of virulence attributes in oral Candida albicans isolates from human immunodeficiency virus-positive individuals
J. Med. Microbiol. 61, 285 (2012); https://doi.org/10.1099/jmm.0.036269-0
/content/journal/jmm/10.1099/jmm.0.036269-0
/content/journal/jmm/10.1099/jmm.0.036269-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error